Target intelligence / Profile preview

RNA, U5A small nuclear 2, pseudogene (RNU5A-2P)

Target
RNU5A-2P
Molecular classification
Other (Small nuclear RNA pseudogene)
01

Overview

RNU5A-2P (RNA U5A small nuclear 2, pseudogene) is a pseudogene that is annotated as a non-protein-coding RNA sequence homologous to the U5A small nuclear RNA gene family[1]. U5 small nuclear RNAs are essential RNA components of the spliceosome—the complex responsible for pre-mRNA splicing in eukaryotic nuclei[3]. However, the "-2P" suffix and annotation as a "pseudogene" indicate this locus is predicted to be non-functional and does not produce a functional snRNA, nor is it associated with a protein product or direct biological activity. It is not a druggable/therapeutic target, receptor, enzyme, or transporter. Most pseudogenes, including RNU5A-2P, are not actively involved in cellular processes or pathology, and there are currently no known interacting drugs, mechanisms of action, or biomarker utility associated with RNU5A-2P. It should not be considered a therapeutic target[1][2]. In summary: This is not a targetable molecule or receptor, but rather a non-coding pseudogene with no known function, clinical or therapeutic significance, or disease association. If you are seeking small nuclear RNA (snRNA) targets or clinically relevant spliceosome subunits, focus should be on functional U5 snRNA genes (e.g., RNU5A-1)[2][3].

Other names
RNU5A-2PRNA U5A small nuclear 2 pseudogene

Beyond the preview

Go deeper on RNA, U5A small nuclear 2, pseudogene (RNU5A-2P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U5A small nuclear 2, pseudogene (RNU5A-2P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call